NEW THERAPEUTIC OPTIONS LIFE THREATENING ARRYTHMIAS
VULNERABLE PATIENT SYMPOSIUM SCA Risk Factors: What are the triggers?
E. Gronda, MD, FESC Cardiology Division Cardiovascular Department IRCCS, H S. Giuseppe, MultiMedica, Group S.S. Giovanni - Milano “Can Neurohormonal Antagonists.
Module 3 chapter 1a
Why Microvolt T-Wave Alternans? l ~10 million patients at elevated risk of SCD l 450,000 sudden deaths per year 1 l ~ONLY 100,000 patients receive life.
Why Microvolt T-Wave Alternans?
